Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3
Clinical trial NCT00001993 · COMPLETED
Trial details
- NCT number
- NCT00001993
- Sponsor
- G D Searle
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.